The Current Role of Methotrexate in Patients With Inflammatory Bowel Disease
- PMID: 33867888
- PMCID: PMC8040907
The Current Role of Methotrexate in Patients With Inflammatory Bowel Disease
Conflict of interest statement
Dr Rosh has received grant/research funding from AbbVie and Janssen, and has served as a consultant for AbbVie, Celgene, Janssen, Lilly, and Pfizer.
Similar articles
-
The bioavailability of oral methotrexate in children with inflammatory bowel disease.J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):445-9. doi: 10.1097/01.mpg.0000157588.27125.50. J Pediatr Gastroenterol Nutr. 2005. PMID: 15795592
-
Low dose methotrexate in inflammatory bowel disease: current status and future directions.Am J Gastroenterol. 2003 Mar;98(3):530-7. doi: 10.1111/j.1572-0241.2003.07305.x. Am J Gastroenterol. 2003. PMID: 12650783 Review.
-
The absorption of low-dose methotrexate in patients with inflammatory bowel disease.Aliment Pharmacol Ther. 1997 Jun;11(3):569-73. doi: 10.1046/j.1365-2036.1997.00175.x. Aliment Pharmacol Ther. 1997. PMID: 9218084
-
Experience with the use of low-dose methotrexate for inflammatory bowel disease.Eur J Gastroenterol Hepatol. 2004 Sep;16(9):921-6. doi: 10.1097/00042737-200409000-00018. Eur J Gastroenterol Hepatol. 2004. PMID: 15316419
-
Methotrexate for inflammatory bowel disease: pharmacology and preliminary results.Mayo Clin Proc. 1996 Jan;71(1):69-80. doi: 10.4065/71.1.69. Mayo Clin Proc. 1996. PMID: 8538238 Review.
Cited by
-
Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease.Life (Basel). 2022 Oct 18;12(10):1623. doi: 10.3390/life12101623. Life (Basel). 2022. PMID: 36295058 Free PMC article. Review.
-
Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study.Biomedicines. 2023 Sep 19;11(9):2575. doi: 10.3390/biomedicines11092575. Biomedicines. 2023. PMID: 37761016 Free PMC article.
-
Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.Sci Rep. 2020 Sep 15;10(1):15131. doi: 10.1038/s41598-020-71674-8. Sci Rep. 2020. PMID: 32934294 Free PMC article.
-
Efficacy of Methotrexate and Anti-TNF Combination Therapy in Adults with Refractory Crohn's Disease.Middle East J Dig Dis. 2024 Oct;16(4):221-224. doi: 10.34172/mejdd.2024.395. Epub 2024 Oct 30. Middle East J Dig Dis. 2024. PMID: 39807419 Free PMC article.
-
Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems.Pharmaceutics. 2024 Sep 7;16(9):1185. doi: 10.3390/pharmaceutics16091185. Pharmaceutics. 2024. PMID: 39339221 Free PMC article. Review.
References
-
- Feagan BG, McDonald JW, Panaccione R et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn’s disease. Gastroenterology. 2014;146(3):681–688.e1. - PubMed
-
- Grossi V, Lerer T, Griffiths A et al. Concomitant use of immunomodulators affects the durability of infliximab therapy in children with Crohn’s disease. Clin Gastroenterol Hepatol. 2015;13(10):1748–1756. - PubMed
LinkOut - more resources
Full Text Sources